<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mp ids='MP_0003674'>Oxidative stress</z:mp> has been associated with the development of blood-brain barrier disruption and cellular injury after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The cytosolic <z:chebi fb="11" ids="22586">antioxidant</z:chebi>, copper/zinc <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase, has been shown to protect against blood-brain barrier disruption and infarction after <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>-reperfusion </plain></SENT>
<SENT sid="2" pm="."><plain>However, it is not clear whether copper/zinc <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase can protect against evolving ischemic lesions after thromboembolic cortical <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>In this study, the photothrombotic <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> model, which is physiologically similar to <z:hpo ids='HP_0001727'>thromboembolic stroke</z:hpo>, was used to develop cortical <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Blood-brain barrier disruption and oxidative cellular damage were investigated in transgenic mice that overexpress copper/zinc <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase and in littermate <z:mp ids='MP_0002169'>wild-type</z:mp> mice after photothrombotic <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, which was induced by both injection of erythrosin B (30 mg/kg) and irradiation using a <z:chebi fb="64" ids="30217">helium</z:chebi> neon laser for 3 min </plain></SENT>
<SENT sid="5" pm="."><plain>Free radical production, particularly <z:chebi fb="1" ids="18421">superoxide</z:chebi>, was increased in the lesioned cortex as early as 4 h after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> using hydroethidine in situ detection </plain></SENT>
<SENT sid="6" pm="."><plain>The transgenic mice showed a prominent decrease in <z:mp ids='MP_0003674'>oxidative stress</z:mp> compared with the <z:mp ids='MP_0002169'>wild-type</z:mp> mice </plain></SENT>
<SENT sid="7" pm="."><plain>Blood-brain barrier disruption, evidenced by quantitation of Evans Blue leakage, occurred 1 h after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and gradually increased up to 24 h </plain></SENT>
<SENT sid="8" pm="."><plain>Compared with the <z:mp ids='MP_0002169'>wild-type</z:mp> mice, the transgenic mice showed less blood-brain barrier disruption, a decrease in oxidative DNA damage using 8-hydroxyguanosine immunohistochemistry, a subsequent decrease in DNA fragmentation using the in situ nick-end labeling technique, and decreased <z:mpath ids='MPATH_124'>infarct</z:mpath> volume after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>From these results we suggest that <z:chebi fb="0" ids="18421">superoxide anion radical</z:chebi> is an important factor in blood-brain barrier disruption and oxidative cellular injury, and that copper/zinc <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase could protect against the evolving infarction after thromboembolic cortical <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
</text></document>